Cargando…
STOML2 restricts mitophagy and increases chemosensitivity in pancreatic cancer through stabilizing PARL-induced PINK1 degradation
Pancreatic cancer remains one of the most lethal diseases with a relatively low 5-year survival rate, and gemcitabine-based chemoresistance occurs constantly. Mitochondria, as the power factory in cancer cells, are involved in the process of chemoresistance. The dynamic balance of mitochondria is un...
Autores principales: | Qin, Cheng, Wang, Yuanyang, Zhao, Bangbo, Li, Zeru, Li, Tianyu, Yang, Xiaoying, Zhao, Yutong, Wang, Weibin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10008575/ https://www.ncbi.nlm.nih.gov/pubmed/36906621 http://dx.doi.org/10.1038/s41419-023-05711-5 |
Ejemplares similares
-
DHX38 restricts chemoresistance by regulating the alternative pre-mRNA splicing of RELL2 in pancreatic ductal adenocarcinoma
por: Li, Zeru, et al.
Publicado: (2023) -
EGR1 induces EMT in pancreatic cancer via a P300/SNAI2 pathway
por: Wang, Yuanyang, et al.
Publicado: (2023) -
Pancreatic cancer stemness: dynamic status in malignant progression
por: Zhao, Yutong, et al.
Publicado: (2023) -
CHRNB2 represses pancreatic cancer migration and invasion via inhibiting β-catenin pathway
por: Qin, Cheng, et al.
Publicado: (2022) -
STOML2 potentiates metastasis of hepatocellular carcinoma by promoting PINK1-mediated mitophagy and regulates sensitivity to lenvatinib
por: Zheng, Yahui, et al.
Publicado: (2021)